Literature DB >> 20334373

Irreversible inhibition of DNA polymerase beta by an oxidized abasic lesion.

Lirui Guan1, Marc M Greenberg.   

Abstract

DNA damage is a source of carcinogenicity and is also the source of the cytotoxicity of gamma-radiolysis and antitumor agents, such as the enediynes. The dioxobutane lesion (DOB) is produced by a variety of DNA-damaging agents, including the aforementioned. Repair of DOB is important for maintaining the integrity of the genome as well as counteracting therapeutic agents that target DNA. We demonstrate that the DOB lesion efficiently and irreversibly inhibits repair by DNA polymerase beta (Pol beta), an integral enzyme in base-excision repair. Irreversible inhibition of Pol beta by DOB suggests that this lesion provides a chemical explanation for the cytotoxicity of drugs that produce it and explains previously unexplained observations in the literature concerning abasic lesions that are not repaired efficiently. Finally, these observations provide the impetus for the design of a new family of inhibitors of Pol beta.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20334373      PMCID: PMC2863033          DOI: 10.1021/ja101372c

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  14 in total

1.  5'-nicked apurinic/apyrimidinic sites are resistant to beta-elimination by beta-polymerase and are persistent in human cultured cells after oxidative stress.

Authors:  J Nakamura; D K La; J A Swenberg
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

2.  Covalent trapping of human DNA polymerase beta by the oxidative DNA lesion 2-deoxyribonolactone.

Authors:  Michael S DeMott; Ergin Beyret; Donny Wong; Brian C Bales; Jae-Taeg Hwang; Marc M Greenberg; Bruce Demple
Journal:  J Biol Chem       Date:  2002-01-22       Impact factor: 5.157

3.  The 2-deoxyribonolactone lesion produced in DNA by neocarzinostatin and other damaging agents forms cross-links with the base-excision repair enzyme endonuclease III.

Authors:  M Hashimoto; M M Greenberg; Y W Kow; J T Hwang; R P Cunningham
Journal:  J Am Chem Soc       Date:  2001-04-04       Impact factor: 15.419

4.  Inhibitors of DNA polymerase beta: activity and mechanism.

Authors:  Zhijie Gao; David J Maloney; Larisa M Dedkova; Sidney M Hecht
Journal:  Bioorg Med Chem       Date:  2008-03-04       Impact factor: 3.641

5.  Self-promoted DNA interstrand cross-link formation by an abasic site.

Authors:  Jonathan T Sczepanski; Aaron C Jacobs; Marc M Greenberg
Journal:  J Am Chem Soc       Date:  2008-07-01       Impact factor: 15.419

6.  Human DNA polymerase beta deoxyribose phosphate lyase. Substrate specificity and catalytic mechanism.

Authors:  R Prasad; W A Beard; P R Strauss; S H Wilson
Journal:  J Biol Chem       Date:  1998-06-12       Impact factor: 5.157

7.  Formation of 1,4-dioxo-2-butene-derived adducts of 2'-deoxyadenosine and 2'-deoxycytidine in oxidized DNA.

Authors:  Bingzi Chen; Choua C Vu; Michael C Byrns; Peter C Dedon; Lisa A Peterson
Journal:  Chem Res Toxicol       Date:  2006-08       Impact factor: 3.739

8.  DNA interstrand cross-link formation by the 1,4-dioxobutane abasic lesion.

Authors:  Lirui Guan; Marc M Greenberg
Journal:  J Am Chem Soc       Date:  2009-10-28       Impact factor: 15.419

9.  Excision of deoxyribose phosphate residues by DNA polymerase beta during DNA repair.

Authors:  Y Matsumoto; K Kim
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

10.  5'-(2-phosphoryl-1,4-dioxobutane) as a product of 5'-oxidation of deoxyribose in DNA: elimination as trans-1,4-dioxo-2-butene and approaches to analysis.

Authors:  Bingzi Chen; Tonika Bohnert; Xinfeng Zhou; Peter C Dedon
Journal:  Chem Res Toxicol       Date:  2004-11       Impact factor: 3.739

View more
  30 in total

1.  An Oxidized Abasic Lesion as an Intramolecular Source of DNA Adducts.

Authors:  Lirui Guan; Marc M Greenberg
Journal:  Aust J Chem       Date:  2011-04-18       Impact factor: 1.321

Review 2.  Base excision repair and lesion-dependent subpathways for repair of oxidative DNA damage.

Authors:  David Svilar; Eva M Goellner; Karen H Almeida; Robert W Sobol
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

3.  Rapid Histone-Catalyzed DNA Lesion Excision and Accompanying Protein Modification in Nucleosomes and Nucleosome Core Particles.

Authors:  Liwei Weng; Marc M Greenberg
Journal:  J Am Chem Soc       Date:  2015-08-20       Impact factor: 15.419

4.  Mutagenic Bypass of an Oxidized Abasic Lesion-Induced DNA Interstrand Cross-Link Analogue by Human Translesion Synthesis DNA Polymerases.

Authors:  Wenyan Xu; Adam Ouellette; Souradyuti Ghosh; Tylor C O'Neill; Marc M Greenberg; Linlin Zhao
Journal:  Biochemistry       Date:  2015-12-14       Impact factor: 3.162

Review 5.  Looking beneath the surface to determine what makes DNA damage deleterious.

Authors:  Marc M Greenberg
Journal:  Curr Opin Chem Biol       Date:  2014-04-22       Impact factor: 8.822

6.  Reactivity of Nucleic Acid Radicals.

Authors:  Marc M Greenberg
Journal:  Adv Phys Org Chem       Date:  2016       Impact factor: 2.833

7.  DNA-Protein Cross-Links: Formation, Structural Identities, and Biological Outcomes.

Authors:  Natalia Y Tretyakova; Arnold Groehler; Shaofei Ji
Journal:  Acc Chem Res       Date:  2015-06-02       Impact factor: 22.384

8.  Oxidative cross-linking of proteins to DNA following ischemia-reperfusion injury.

Authors:  Arnold Groehler; Stefan Kren; Qinglu Li; Maggie Robledo-Villafane; Joshua Schmidt; Mary Garry; Natalia Tretyakova
Journal:  Free Radic Biol Med       Date:  2018-03-11       Impact factor: 7.376

9.  Abasic and oxidized abasic site reactivity in DNA: enzyme inhibition, cross-linking, and nucleosome catalyzed reactions.

Authors:  Marc M Greenberg
Journal:  Acc Chem Res       Date:  2013-12-26       Impact factor: 22.384

10.  DNA damage by C1027 involves hydrogen atom abstraction and addition to nucleobases.

Authors:  Joanna Maria N San Pedro; Terry A Beerman; Marc M Greenberg
Journal:  Bioorg Med Chem       Date:  2012-06-09       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.